Bioventus (BVS) Tax Rate (2020 - 2026)
Bioventus' (BVS) quarterly Tax Rate came in at 136.51% in Q2 2026, down 14660.0% on a YoY basis from N/an in Q2 2025, and down 1179.89% quarter-over-quarter from 12.64% in Q1 2026.
Powered by 
Analysis
Bioventus (BVS) Tax Rate (2020 - 2026) Analysis & Trends
Bioventus (BVS) has reported Tax Rate for 7 consecutive years, with 136.51% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate fell 14660.0% year-over-year to 136.51%; the trailing twelve-month figure through Jun 2026 stood at 59.11% (down 19073.0% YoY), and the FY2025 full-year result was 6.09%, down 1620.0% from the prior year.
- Tax Rate slipped to 136.51% in Q2 2026 per BVS's latest filing, from 12.64% in the prior quarter.
- Across five years, Tax Rate topped out at 33.79% in Q4 2022 and bottomed at 1037.74% in Q4 2024.
- Historically, Tax Rate has averaged 61.7% across 5 years, with a median of 1.46% in 2025.
- The sharpest annual moves came in 2024 and 2025: Tax Rate plunged 104666 bps in 2024, then soared 101529 bps in 2025.
- Over 5 years, Tax Rate stood at 33.79% in 2022, then slumped by 74 bps to 8.92% in 2023, then plunged by 11731 bps to 1037.74% in 2024, then surged by 98 bps to 22.45% in 2025, then sank by 508 bps to 136.51% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 136.51%, 12.64%, and 22.45% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 39.11% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 21.94% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 16.34% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 18.41% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 53.56% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -100.00% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 21.54% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 26.51% |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | -136.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -136.51% |
| Mar 28, 2026 | 12.64% |
| Dec 31, 2025 | -22.45% |
| Sep 27, 2025 | 14.22% |
| Jun 28, 2025 | 10.09% |
| Mar 29, 2025 | 2.78% |
| Dec 31, 2024 | -1,037.74% |
| Sep 28, 2024 | -11.20% |
| Jun 29, 2024 | 17.66% |
| Mar 30, 2024 | -16.57% |
| Dec 31, 2023 | 8.92% |
| Sep 30, 2023 | -7.33% |
| Jul 1, 2023 | -8.76% |
| Apr 1, 2023 | 0.15% |
| Dec 31, 2022 | 33.79% |
| Oct 1, 2022 | 22.61% |
| Jul 2, 2022 | -19.17% |
| Apr 2, 2022 | 26.27% |
| Dec 31, 2021 | 99.09% |
| Oct 2, 2021 | 27.99% |